Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignanciesJosé María Sánchez‐Pina, María Calbacho, Rosa Ayala et al.|European Journal Of Haematology|2020Cited by 96
The Minimal Residual Disease Using Liquid Biopsies in Hematological MalignanciesRafael Colmenares, Rosa Ayala, Noemí Álvarez et al.|Cancers|2022Cited by 41
Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global networkA. Sanz, Joaquín Martínez‐López, Rosa Ayala et al.|Blood Cancer Journal|2022Cited by 24
Minimal Residual Disease Using Liquid Biopsies in Hematological MalignanciesRafael Colmenares, Rosa Ayala, Noemí Álvarez et al.|Preprints.org|2022Cited by 13
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple MyelomaLarissa Haertle, Joaquín Martínez‐López, Natalia Buenache et al.|Cancers|2023Cited by 12